Test-Retest Reliability of Remote Assessments in Patients With Myotonic Dystrophy Type 1

Remote assessments are feasible and safe. Many measurements demonstrate high reliability, show adequate measurement sensitivity, and correlate with PROs. These findings support remote research, facilitating broad participation, and reducing participant burden.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2026-02-25
DOI
https://doi.org/10.1212/wnl.0000000000214615
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Test-Retest Reliability of Remote Assessments in Patients With Myotonic Dystrophy Type 1

Eleanor Stanton, Jeanne Dekdebrun, Chandani Warnasooriya, Johanna Hamel et al.
Neurology
Genetic Neurodegenerative Diseases
article

Test-Retest Reliability of Remote Assessments in Patients With Myotonic Dystrophy Type 1

Eleanor Stanton, Jeanne Dekdebrun, Chandani Warnasooriya, Johanna Hamel, Katy Eichinger, Mikaella Docteur, Erin Richardson, Laura Tufano
article en

Abstract

Remote assessments are feasible and safe. Many measurements demonstrate high reliability, show adequate measurement sensitivity, and correlate with PROs. These findings support remote research, facilitating broad participation, and reducing participant burden.

NeurologyVol. 106(6)
University of Rochester Medical Center (US), Sapienza University of Rome (IT)
Openalex Percentile: Top 43%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.